View:
DEFA14A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.    )

 

 

Filed by the Registrant  ☒                     Filed by a party other than the Registrant  ☐

Check the appropriate box:

 

Preliminary Proxy Statement

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

Definitive Proxy Statement

 

Definitive Additional Materials

 

Soliciting Material Pursuant to Section 240.14a-12

Aerie Pharmaceuticals, Inc.

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

 

No fee required.

 

Fee paid previously with preliminary materials.

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 

 


                                  
                        
   

 

Your Vote Counts!

          
 

 

AERIE PHARMACEUTICALS, INC.

 

2022 Annual Meeting

Vote by June 8, 2022

11:59 PM ET

 

        
   

 

AERIE PHARMACEUTICALS, INC.

4301 EMPEROR BOULEVARD, SUITE 400

DURHAM, NC 27703

 

LOGO         

                    

   
   
   
     
     

    

     
 
 
              
 
     
                                       
            

You invested in AERIE PHARMACEUTICALS, INC. and it’s time to vote!

You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the stockholder meeting to be held on June 09, 2022.

Get informed before you vote

View the Notice & Proxy Statement, Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to May 26, 2022. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.

 

     LOGO

 

 

* Please check the meeting materials for any special requirements for meeting attendance.

 


Vote at www.ProxyVote.com

 

 

THIS IS NOT A VOTABLE BALLOT

This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters.

 

     Voting Items  

Board

Recommends

 
1.  

Election of Directors

 

Nominees:

 

  LOGO  For
    01)    R. Croarkin                                02)    P. McDonnell    
 
2.   Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.   LOGO  For
 
3.       To approve, by a non-binding vote, the compensation of our named executive officers (“say-on-pay”).   LOGO  For
NOTE: Such other business as may properly come before the meeting or any adjournment thereof.
      

 

 

Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Sign up for E-delivery”.